deltatrials
Completed PHASE4 NCT00859079

Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients

Efficacy of a Continuous GLP-1 Infusion in Comparison to a Structured Insulin Infusion Protocol to Reach Normoglycemia in Non-Fasted Type 2 Diabetic Patients

Sponsor: Medical University of Graz

Conditions Diabetes Mellitus Type 2 Hyperglycemia
Interventions GLP-1 Human regular insulin intravenously
Updated 5 times since 2017 Last updated: Mar 9, 2009 Started: Jun 30, 2006 Primary completion: Dec 31, 2006 Completion: Jan 31, 2007

Listed as NCT00859079, this PHASE4 trial focuses on Diabetes Mellitus Type 2 and Hyperglycemia and remains completed. Sponsored by Medical University of Graz, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jun 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical University of Graz
Data source: Medical University of Graz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Graz, Austria